/Investor DB

Walden Catalyst — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Genome Medicalgenomemedical.comin𝕏Series B · Jul 2020 · $14M

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

Lisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inElizabeth Moreno(Executive Officer)inMark Sylvester(Chief Financial Officer)inAndrew Warner(Vice President, Product)in

Co-investorsAlumni VenturesAvestria VenturesBlue Ivy VenturesCanaan PartnersDreamers VCEcho Health Ventures+13 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.